CHRONIC POLYPOSIS RHINOSINUSITIS

Authors

  • NASRETDINOVA Makhzuna Taxsinovna
  • OMONOVA Maftuna Shavkat qizi

Keywords:

Polypous rhinosinusitis (PRS), glucocorticosteroids, polypotomy

Abstract

In recent years, there has been a noticeable increase in the proportion of polypous rhinosinusitis in the structure of diseases of the nasal cavity and paranasal sinuses, which is due to a number of factors: changes in the environmental situation, an increase in the number of bacterial, viral and occupational pathogenic agents. The use of combined treatment regimens using topical and systemic corticosteroids to date shows encouraging results, but requires further standardization in terms of the choice of drugs and their duration of administration, and safety monitoring.

References

Varvyanskaya A. V., Lopatin A. S. The effectiveness of long-term treatment of polypous rhinosinusitis with low doses of macrolides. Vestnik otorinolaringologii. 2013;78(5): 22–27. doi: 10.1002/alr.21318. (in Russ)

Klinicheskie rekomendacii Nacionalnogo soglasitelnogo komiteta “Polipozniy rinosinusit”. М. 2010. (in Russ)

Epidemiologiya polipoznix rinosinusitov Lancov A.A. Ryazancev S.V. СПб., 1999. 96 с. (in Russ)

Polipoznyi rinosinusit. Klinicheskie rekomendatsii. Natsional’naya assotsiatsiya otorinolaringologov, 2016. 21 p. (in Russ.).

Savlevich E. L., Kozlov V. S., Kurbacheva O. M. Modern trends in the diagnostic and treatment of chronic rhinosinusitis with nasal polyps. Rossiiskaya rinologiya. 2018;26(2):41–47. (in Russ.)

Savlevich E. L., Khaidukov S. V., Kurbacheva O. М., Bondareva G. P., Shachnev K. N., Simbirtsev A. S. Characteristics of cellular immune status in the patients with chronic rhinosinusitis with nasal polyps. Medical Immunology. 2017;19(6):731–738 (in Russ.).

Ahmadiafshar A, Farjd HR, Moezzi F, Mousavinasab N. Nasal polyposis in patients with asthma and allergic rhinitis. J Laryngol Otol. 2012;126(8):780-783.

Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607-614.

Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwen- berge P, Liu S, Lin P, Bousquet J, Van Steen K. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immu¬ nol. 2010;126(5):962-968.

Bhattacharyya N., Kepnes L. J. Medications prescribed at ambulatory visits for nasal polyposis. Am J Rhinol Allergy. 2013;27:479-481.

Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope. 1991;101:56-64.

Bunnag C, Pacharee P, Vipulakom P, Siriyananda C. A study of allergic factor in nasal polyp patients. Ann Allergy. 1983;50(2):126- 132.

Chen Y. T. [et al.]. Asthma associated with chronic rhinosinusitis: a population-based study. International Forum of Allergy and Rhinology. 2016;12(6):1284–1293.

Dabirmoghaddam P., Mehdizadeh Seraj J., Bastaninejad S., Meighani A., Mokhtari Z. The efficacy of clarithromycin in patients with severe nasal polyposis. ActaMed Iran. 2013;51:359-364. 4430

Shakhanova Sh.Sh., Abdurakhmonov J.A., Rakhimov, N.M.. (2023). Targeted therapy in the palliative treatment of platinum-resistant recurrent ovarian cancer complicated by ascites. The American Journal of Medical Sciences and Pharmaceutical Research, 5(08), 77–81.

Demarco R.C, Tamashiro E, Rossato M, Ferreira MD, Valera FC, Anselmo-Lima WT. Ciliary ultrastructure in patients with chronic rhinosinusitis and primary ciliary dyskinesia. Eur Arch Oto Rhino Laryngol. 2013;270(7):2065-2070.

Статья поступила в редакцию 30.10.2023; одобрена после рецензирования 22.12.2023; принята к публикации 25.12.2023.

The article was submitted 30.10.2023; approved after reviewing 22.12.2023; accepted for publication 25.12.2023.

Информация об авторах:

Насретдинова Махзуна Тахсиновна- доктор медицинских наук, профессор. Заведующая кафедры оториноларингологии №2 Самаркандского Государственного медицинского университетa, Узбекистан. E-mail: luna1088@mail.ru, https://orcid.org/0000-0001-7643-2334

Омонова Мафтуна Шавкат қизи- докторант 1 курса обучения кафедры Оториноларингологии №2 Самаркандского государственного медицинского университета, Самарканд, Узбекистан. Е-mail: o.maftuna1996@gmail.com, , https://orcid.org/0004-0003-8401-2104

Источники финансирования: Работа не имело специального финансирования

Конфликт интересов: авторы декларируют отсуствие явных и потенциальных конфликтов интересов, связанных спубликацией настоящей статьи.

Вклад авторов:

Насретдинова М.Т. – идеологияческая концепция работы; написание текста, редактирование статьи;

Омонова М.Ш.– сбор и анализ источников литературы, написание текста.

Information about the authors:

Nasretdinova Makhzuna Takhsinovna - Doctor of Medical Sciences, Professor. Head of the Department of Otorhinolaryngology No. 2 of the Samarkand State Medical University, Uzbekistan. E-mail: luna1088@mail.ru, https://orcid.org/0000-0001-7643-2334

Maftuna Sh.Omonova —first year doctoral student at Samarkand state medical university. Samarkand, Uzbekistan; E-mail: o.maftuna1996@gmail.com, https://orcid.org/0004-0003-8401-2104

Sources of financing:The work did not have special funding

Conflict of interest: the authors declare no obvious or potential

conflicts of interest related to the publication of this article.

Authors' contributions:

Nasretdinova M.T. – ideological concept of work; writing the text, editing the article;

Omonova M.Sh. – collection and analysis of literature sources, writing the text.

Published

2024-01-31